Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody.

Richardson SI, Lambson BE, Crowley AR, Bashirova A, Scheepers C, Garrett N, Abdool Karim S, Mkhize NN, Carrington M, Ackerman ME, Moore PL, Morris L.

PLoS Pathog. 2019 Dec 16;15(12):e1008064. doi: 10.1371/journal.ppat.1008064. eCollection 2019 Dec.

2.

Disulfide Bond Engineering of an Endoglucanase from Penicillium verruculosum to Improve Its Thermostability.

Bashirova A, Pramanik S, Volkov P, Rozhkova A, Nemashkalov V, Zorov I, Gusakov A, Sinitsyn A, Schwaneberg U, Davari MD.

Int J Mol Sci. 2019 Mar 30;20(7). pii: E1602. doi: 10.3390/ijms20071602.

3.

Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.

McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, Bashirova A, Buchbinder S, Carrington MN, Cossarizza A, Dalmau J, De Luca A, Goedert JJ, Gurdasani D, Haas DW, Herbeck JT, Johnson EO, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, Poli G, Sandhu MS, Schuitemaker H, Shea PR, Theodorou I, Walker BD, Weintrob AC, Winkler CA, Wolinsky SM, Raychaudhuri S, Goldstein DB, Telenti A, de Bakker PI, Zagury JF, Fellay J.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14658-63. doi: 10.1073/pnas.1514867112. Epub 2015 Nov 9.

4.

Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.

Olesen R, Vigano S, Rasmussen TA, Søgaard OS, Ouyang Z, Buzon M, Bashirova A, Carrington M, Palmer S, Brinkmann CR, Yu XG, Østergaard L, Tolstrup M, Lichterfeld M.

J Virol. 2015 Oct;89(20):10176-89. doi: 10.1128/JVI.01484-15. Epub 2015 Jul 29.

5.

On stand by: host genetics of HIV control.

Carrington M, Bashirova AA, McLaren PJ.

AIDS. 2013 Nov 28;27(18):2831-9. doi: 10.1097/01.aids.0000432536.85335.c8. Review.

PMID:
25119688
6.

HLA class I and KIR genes do not protect against HIV type 1 infection in highly exposed uninfected individuals with hemophilia A.

Vince N, Bashirova AA, Lied A, Gao X, Dorrell L, McLaren PJ, Fellay J, Carrington M.

J Infect Dis. 2014 Oct 1;210(7):1047-51. doi: 10.1093/infdis/jiu214. Epub 2014 Apr 8.

7.

LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.

Bashirova AA, Martin-Gayo E, Jones DC, Qi Y, Apps R, Gao X, Burke PS, Taylor CJ, Rogich J, Wolinsky S, Bream JH, Duggal P, Hussain S, Martinson J, Weintrob A, Kirk GD, Fellay J, Buchbinder SP, Goedert JJ, Deeks SG, Pereyra F, Trowsdale J, Lichterfeld M, Telenti A, Walker BD, Allen RL, Carrington M, Yu XG.

PLoS Genet. 2014 Mar 6;10(3):e1004196. doi: 10.1371/journal.pgen.1004196. eCollection 2014 Mar.

8.

Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.

Bashirova AA, Apps R, Vince N, Mochalova Y, Yu XG, Carrington M.

Immunogenetics. 2014 Jan;66(1):1-8. doi: 10.1007/s00251-013-0730-9. Epub 2013 Oct 6.

9.

HLA/KIR restraint of HIV: surviving the fittest.

Bashirova AA, Thomas R, Carrington M.

Annu Rev Immunol. 2011;29:295-317. doi: 10.1146/annurev-immunol-031210-101332. Review.

10.

HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN).

Chung NP, Breun SK, Bashirova A, Baumann JG, Martin TD, Karamchandani JM, Rausch JW, Le Grice SF, Wu L, Carrington M, Kewalramani VN.

J Biol Chem. 2010 Jan 15;285(3):2100-12. doi: 10.1074/jbc.M109.030619. Epub 2009 Oct 15.

11.

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR; HALT-C Trial Group.

Hepatology. 2009 Jun;49(6):1847-58. doi: 10.1002/hep.22877.

12.

The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates.

Ortiz M, Kaessmann H, Zhang K, Bashirova A, Carrington M, Quintana-Murci L, Telenti A.

Genes Immun. 2008 Sep;9(6):483-92. doi: 10.1038/gene.2008.40. Epub 2008 Jun 5.

13.

Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?

Thomas R, Yamada E, Alter G, Martin MP, Bashirova AA, Norman PJ, Altfeld M, Parham P, Anderson SK, McVicar DW, Carrington M.

J Immunol. 2008 May 15;180(10):6743-50.

14.

Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry.

Yu KJ, Bashirova A, Madeleine MM, Cheng J, Johnson LG, Schwartz SM, Carrington M, Hildesheim A.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2504-8.

15.

[Morphology of acute lung injuries in mechanic trauma].

Sundukov DV, Golubev AM, Alisievich VI, Bashirova AR.

Sud Med Ekspert. 2007 Jul-Aug;50(4):3-5. Russian.

PMID:
17718078
16.

Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes.

Gillespie GM, Bashirova A, Dong T, McVicar DW, Rowland-Jones SL, Carrington M.

AIDS Res Hum Retroviruses. 2007 Mar;23(3):451-5.

PMID:
17411378
17.

Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.

Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, Yawata M, Easterbrook P, McVicar DW, Maenaka K, Parham P, Carrington M, Dong T, Rowland-Jones S.

J Immunol. 2007 Jan 1;178(1):33-7.

18.

Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.

Thio CL, Astemborski J, Bashirova A, Mosbruger T, Greer S, Witt MD, Goedert JJ, Hilgartner M, Majeske A, O'Brien SJ, Thomas DL, Carrington M.

J Virol. 2007 Jan;81(2):441-5. Epub 2006 Nov 1.

19.

Identification of the ancestral killer immunoglobulin-like receptor gene in primates.

Sambrook JG, Bashirova A, Andersen H, Piatak M, Vernikos GS, Coggill P, Lifson JD, Carrington M, Beck S.

BMC Genomics. 2006 Aug 15;7:209.

20.

The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense.

Bashirova AA, Martin MP, McVicar DW, Carrington M.

Annu Rev Genomics Hum Genet. 2006;7:277-300. Review.

PMID:
16824023
21.

Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1.

Bashirova AA, Bleiber G, Qi Y, Hutcheson H, Yamashita T, Johnson RC, Cheng J, Alter G, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, May M, Maldarelli F, Jacobson L, O'brien SJ, Telenti A, Carrington M.

J Virol. 2006 Jul;80(14):6757-63.

22.

AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.

Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Altfeld M, O'Brien SJ, Carrington M.

Nat Med. 2005 Dec;11(12):1290-2. Epub 2005 Nov 20.

PMID:
16288280
23.

Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates.

Sambrook JG, Bashirova A, Palmer S, Sims S, Trowsdale J, Abi-Rached L, Parham P, Carrington M, Beck S.

Genome Res. 2005 Jan;15(1):25-35.

24.

Cutting edge: expansion of the KIR locus by unequal crossing over.

Martin MP, Bashirova A, Traherne J, Trowsdale J, Carrington M.

J Immunol. 2003 Sep 1;171(5):2192-5.

25.

Novel member of the CD209 (DC-SIGN) gene family in primates.

Bashirova AA, Wu L, Cheng J, Martin TD, Martin MP, Benveniste RE, Lifson JD, KewalRamani VN, Hughes A, Carrington M.

J Virol. 2003 Jan;77(1):217-27.

26.

Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN.

Wu L, Bashirova AA, Martin TD, Villamide L, Mehlhop E, Chertov AO, Unutmaz D, Pope M, Carrington M, KewalRamani VN.

Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1568-73. Epub 2002 Jan 29.

27.

A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection.

Bashirova AA, Geijtenbeek TB, van Duijnhoven GC, van Vliet SJ, Eilering JB, Martin MP, Wu L, Martin TD, Viebig N, Knolle PA, KewalRamani VN, van Kooyk Y, Carrington M.

J Exp Med. 2001 Mar 19;193(6):671-8.

28.
29.

The human RIL gene: mapping to human chromosome 5q31.1, genomic organization and alternative transcripts.

Bashirova AA, Markelov ML, Shlykova TV, Levshenkova EV, Alibaeva RA, Frolova EI.

Gene. 1998 Apr 14;210(2):239-45.

PMID:
9573374

Supplemental Content

Loading ...
Support Center